BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » Glucagone regulates its own synthesis

Glucagone regulates its own synthesis

Once a hormone is released it can stimulate its own production. This principle was previously proven by Professor Berggren’s group in relation to insulin. Now the same group shows the generality of the approach: glucagon secreting cells increase their production when they sense increasing levels of glucagon. The results are published in PNAS in December 2012.

Hormones are powerful regulators of various biological processes. To ensure that there is always enough supply of the hormones, their secretion and production must be coupled. A simple but efficient way to provide such regulation is through an autocrine signalling, in which the molecules are sensed by those cells that produce them. Secretion and production of insulin by the pancreatic beta cells are connected via this positive autocrine feedback mechanism. It has though been considered to be an exception more than a rule due to the role that insulin plays in controlling blood sugar concentrations.

Glucagon is a peptide hormone secreted by alpha cells in the islets of Langerhans. This hormone has a role opposite to that of insulin: glucagon increases levels of blood sugar to avoid a dangerous state of hypoglycemia*. It is therefore of vital importance to have an absolute control of the blood glucagon levels.

Researchers in Professor Berggren’s group have recently shown that as in the case with insulin production, glucagon production is also regulated via autocrine signalling. Alpha cell have special receptors that sense secreted glucagon and translate the signal into increased production levels to ‘stock up’ the hormone for future use. Therefore, the positive autocrine feedback mechanism is a more general principle for hormone-secreting cells than previously anticipated.

* Hypoglycemia – dangerously low blood sugar concentration, a state that heavily affects the brain’s functions and possibly results in death.

Read more:

Glucagon regulates its own synthesis by autocrine signaling. Barbara Leibiger, Tilo Moede, Thusitha P. Muhandiramlage, Daniel Kaiser, Pilar Vaca Sanchez, Ingo B. Leibiger, and Per-Olof Berggren. Proceedings of the National Academy of Sciences (PNAS). Early Edition 3-7 December 2012

December 27, 2012 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved